Viewing Study NCT06237569


Ignite Creation Date: 2025-12-24 @ 10:48 PM
Ignite Modification Date: 2025-12-25 @ 8:18 PM
Study NCT ID: NCT06237569
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-02-01
First Post: 2024-01-12
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Dose Low Dose Ketamine in Casesarian
Sponsor: Inonu University
Organization:

Study Overview

Official Title: Effects of Low Dose ketamıne on Postpartum Depression During Caesarean Sections
Status: NOT_YET_RECRUITING
Status Verified Date: 2024-01
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The results of ketamine, ketamine and midazolom and placebo can be copied after birth in cesareans subjected to spinal anesthesia.
Detailed Description: Postpartum depression will be evaluated by dividing the patients into 3 groups: group 1 as ketamine, group 2 as ketamine and midasom, and group 3 as placebo group.

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: